Phase II study of S-1 and irinotecan combination chemotherapy as a first-line therapy for patients with advanced gastric cancer. Korean Cancer Study Group Protocol ST05-02
2009 ◽
Vol 5
(1)
◽
pp. 46-54
◽
Keyword(s):
Phase Ii
◽